- ongoing, recruitingPhase II and Phase III (Integrated)
A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid
This study is looking into a new medicine, efgartigimod, for people with bullous pemphigoid (BP). It compares efgartigimod to a dummy drug (placebo) to see if it can help patients achieve clear skin without needing steroid tablets for a long time.
Czechia · Italy · Spain - enrolling by invitationPHASE1
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
This study is looking at a new treatment called RAY121 for people with certain immune conditions like lupus-like disorders, skin blistering, or blood problems. It's a long-term follow-up for people who did well in an earlier study, to see how RAY121 works over time and if it continues to help.
Australia · Austria · Bulgaria - recruitingPHASE1
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
This study is testing a new medicine, RAY121, for several immune system diseases like Antiphospholipid Syndrome and Behçet's Syndrome. Researchers want to see if RAY121 is safe and how it works in the body. It's an early-stage trial.
United States · Australia · Austria